The study published in eClinicalMedicine by Huilin Tang and colleagues from the University of Pennsylvania Perelman School of ...

By extending survival, GLP-1 agents may expand the dementia risk period for diabetes patie ...

The findings, published as a Research Letter in JAMA Internal Medicine by Bryant Shuey and colleagues from the University of ...

Online personalities and individual social media users have for years hawked yerba mate and fiber products as methods to ...

Scientists have discovered natural GLP-1 in joint fluid, which could open up a new treatment option for arthritis.

Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella ...

As many of us know, keeping weight in check can be hard. National data reflect that reality. Rates of overweight and obesity in the U.S. have steadily climbed since the early 1980s. The impact on ...

At this year's American Society of Regional Anesthesia and Pain Medicine (ASRA) annual meeting, researchers at Hospital for Special Surgery (HSS) presented two studies focused on glucagon-like peptide ...

Exert BodySculpt, a body contouring practice led by Dr. Giselle Prado-Wright, has published clinical guidance on the growing ...

Updates GLP drugs pricing and access highlight new subscription models, FDA approvals, and tighter regulatory oversight in 2024.

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial ...

Research suggests GLP-1 drugs like Ozempic and Wegovy could double divorce risk, mirroring trends seen in bariatric surgery ...